- Report
- June 2024
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 185 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- October 2024
- 181 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 181 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- August 2024
Global
From €2329EUR$2,450USD£1,957GBP
- Report
- March 2025
- 183 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 172 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 196 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 504 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 510 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 181 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP

The Neurodegenerative Disease market is a subset of the Neurosciences field that focuses on the diagnosis, treatment, and prevention of diseases that cause the progressive loss of structure or function of neurons, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS). These diseases are characterized by the gradual degeneration of the nervous system, leading to a decline in cognitive and motor functions. Treatment options for these diseases are limited, and there is currently no cure.
The Neurodegenerative Disease market is composed of a variety of companies, including pharmaceutical companies, biotechnology companies, medical device companies, and research organizations. Examples of companies in this market include AbbVie, Biogen, Novartis, Merck, and Pfizer. Show Less Read more